[HTML][HTML] Adverse events related to COVID-19 vaccines: the need to strengthen pharmacovigilance monitoring systems
S Shrestha, J Khatri, S Shakya, K Danekhu… - Drugs & Therapy …, 2021 - Springer
Abstract Coronavirus disease 2019 (COVID-19) is an infectious disease caused by a new
species of β-coronavirus genus named severe acute respiratory syndrome coronavirus 2 …
species of β-coronavirus genus named severe acute respiratory syndrome coronavirus 2 …
Adverse events related to COVID-19 vaccines: the need to strengthen pharmacovigilance monitoring systems
S Shrestha, J Khatri, S Shakya… - Drugs & therapy …, 2021 - pubmed.ncbi.nlm.nih.gov
Coronavirus disease 2019 (COVID-19) is an infectious disease caused by a new species of
β-coronavirus genus named severe acute respiratory syndrome coronavirus 2. The COVID …
β-coronavirus genus named severe acute respiratory syndrome coronavirus 2. The COVID …
Adverse events related to COVID-19 vaccines: the need to strengthen pharmacovigilance monitoring systems.
S Shrestha, J Khatri, S Shakya, K Danekhu… - Drugs & Therapy …, 2021 - europepmc.org
Abstract Coronavirus disease 2019 (COVID-19) is an infectious disease caused by a new
species of β-coronavirus genus named severe acute respiratory syndrome coronavirus 2 …
species of β-coronavirus genus named severe acute respiratory syndrome coronavirus 2 …
Adverse events related to COVID-19 vaccines: The need to strengthen pharmacovigilance monitoring systems
S Shrestha, J Khatri, S Shakya… - Drugs & Therapy …, 2021 - research-portal.uea.ac.uk
Abstract Coronavirus disease 2019 (COVID-19) is an infectious disease caused by a new
species of β-coronavirus genus named severe acute respiratory syndrome coronavirus 2 …
species of β-coronavirus genus named severe acute respiratory syndrome coronavirus 2 …
[HTML][HTML] Adverse events related to COVID-19 vaccines: the need to strengthen pharmacovigilance monitoring systems
S Shrestha, J Khatri, S Shakya, K Danekhu… - Drugs & Therapy …, 2021 - ncbi.nlm.nih.gov
Abstract Coronavirus disease 2019 (COVID-19) is an infectious disease caused by a new
species of β-coronavirus genus named severe acute respiratory syndrome coronavirus 2 …
species of β-coronavirus genus named severe acute respiratory syndrome coronavirus 2 …
Adverse events related to COVID-19 vaccines: the need to strengthen pharmacovigilance monitoring systems
S Shrestha, J Khatri, S Shakya… - Drugs & Therapy …, 2021 - search.proquest.com
Abstract Coronavirus disease 2019 (COVID-19) is an infectious disease caused by a new
species of ß-coronavirus genus named severe acute respiratory syndrome coronavirus 2 …
species of ß-coronavirus genus named severe acute respiratory syndrome coronavirus 2 …
[PDF][PDF] Adverse events related to COVID‑19 vaccines: the need to strengthen pharmacovigilance monitoring systems
S Shrestha, J Khatri, S Shakya, K Danekhu… - Drugs & Therapy …, 2021 - academia.edu
Abstract Coronavirus disease 2019 (COVID-19) is an infectious disease caused by a new
species of β-coronavirus genus named severe acute respiratory syndrome coronavirus 2 …
species of β-coronavirus genus named severe acute respiratory syndrome coronavirus 2 …
Adverse events related to COVID-19 vaccines: the need for strengthening pharmacovigilance monitoring systems
S Shrestha, J Khatri, S Shakya… - Drugs & Therapy …, 2021 - research.birmingham.ac.uk
Abstract Coronavirus disease 2019 (COVID-19) is an infectious disease caused by a new
species of β-coronavirus genus named severe acute respiratory syndrome coronavirus 2 …
species of β-coronavirus genus named severe acute respiratory syndrome coronavirus 2 …
Adverse events related to COVID-19 vaccines: The need to strengthen pharmacovigilance monitoring systems
S Shrestha, J Khatri, S Shakya… - Drugs & Therapy …, 2021 - ueaeprints.uea.ac.uk
Coronavirus disease 2019 (COVID-19) is an infectious disease caused by a new species of
β-coronavirus genus named severe acute respiratory syndrome coronavirus 2. The COVID …
β-coronavirus genus named severe acute respiratory syndrome coronavirus 2. The COVID …
[PDF][PDF] Adverse events related to COVID‑19 vaccines: the need to strengthen pharmacovigilance monitoring systems
S Shrestha, J Khatri, S Shakya, K Danekhu… - Drugs & Therapy …, 2021 - academia.edu
Abstract Coronavirus disease 2019 (COVID-19) is an infectious disease caused by a new
species of β-coronavirus genus named severe acute respiratory syndrome coronavirus 2 …
species of β-coronavirus genus named severe acute respiratory syndrome coronavirus 2 …